In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147
about
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer TherapyCurrent status of biomarkers for prostate cancerDisseminated tumor cells and dormancy in prostate cancer metastasisProstate cancer relevant antigens and enzymes for targeted drug deliveryA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsElevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer.Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature.The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literatureHyaluronan-CD44 interaction promotes growth of decidual stromal cells in human first-trimester pregnancy.CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.Expression of CD44 in pancreatic cancer and its significanceMolecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxelEMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique.A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.Roadblocks to translational advances on metastasis research.Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes.Prognostic significance of CD147 in patients with glioblastoma.Micro-engineered perfusable 3D vasculatures for cardiovascular diseases.miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.CD44 is overexpressed and correlated with tumor progression in gallbladder cancerCholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer StemnessEpithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
P2860
Q24337757-55A06424-B784-4EF1-A714-4CF84A3A5546Q24600574-B3F31FAF-69AA-4C4E-859F-66708260CE37Q26768484-21021F1D-ADAA-4018-8C41-3CE20B3C7923Q27013843-D46B249B-F7B0-4D35-A21E-0374755C8F73Q28573536-1BD97CCA-8567-40F0-A384-40196794B5C6Q33914079-BC7C9E8F-8A56-441F-83FE-F3B8C931737BQ34123665-1C544FF3-9210-4614-AD7A-1A9D67437D3EQ34486547-88D6BE09-EFD6-4CAB-AD3E-242F6909EB31Q34999342-05FDC243-7F3A-4697-86D3-D9779DED7344Q35116847-52F18DCA-4BD0-4DD6-934C-64EC230D8332Q35402326-7FA6FF94-FE6E-437A-8FB1-8A442E77A695Q35919121-CE1D77AD-F148-4F20-AEE3-5BC85AF5B937Q36356460-A508BDCF-3D44-4773-A434-F73FFE75EAACQ36644344-FF1873A9-BE7B-4F22-B8F8-6F7C13A13D35Q36707148-A7FA4D85-1204-4051-A1B9-215C295D81A1Q37589853-EE9316D7-6696-4EE1-A93B-E9CDBEC21DA2Q37657753-4DB5376D-22A7-4B9A-A3E0-16535A99CA90Q37679393-A8D4EF11-4F87-4B21-A71E-70CFF7E12A99Q37687556-2F83D2BC-0F5A-4592-B267-B7A91300E929Q38722797-1D3F7784-84CD-4A3E-95BA-3D6DF98D6EABQ38949683-9D42E6C4-1C39-4FB2-994E-FA7C39FEB665Q38980036-4F5C2217-346E-4FD2-9102-EE9DC05045DBQ39070920-22C341A4-649D-4C54-8CD1-942B15D9425FQ39085736-892226A2-D0CF-4D75-9313-C0B298F85D04Q43686572-0CFE88DB-550F-4D18-A3E9-2308262CA25AQ47884241-F9E7B3F9-0848-4DB3-A827-6034A677B3A1Q50214807-A2AC0A9F-44CF-4C26-B5B5-E8073DE219A2Q53059665-E23E86D0-4386-4DFD-B56E-58D8967A1B0EQ57070165-8BF09402-148B-4BE1-8949-732B500C42DEQ58612678-5B77C81F-303F-4C03-BC4B-DA8246206136Q59136173-3382C73F-8B16-4F31-9BBB-01507E0B931F
P2860
In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@ast
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@en
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@nl
type
label
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@ast
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@en
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@nl
prefLabel
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@ast
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@en
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@nl
P2093
P2860
P3181
P1433
P1476
In vitro and in vivo prostate ...... ession of either CD44 or CD147
@en
P2093
Aparajita Khatri
Carl A Power
Jingli Hao
John H Kearsley
Julia Beretov
Michele C Madigan
Paul J Cozzi
Peter H Graham
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0040716
P407
P577
2012-08-03T00:00:00Z